{"id":62156,"title":"Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-?, as therapy for previously treated indolent non-Hodgkin lymphoma.","abstract":"","date":"2014-05-30","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24615776","annotations":[{"name":"Enzyme inhibitor","weight":0.430141,"wikipedia_article":"http://en.wikipedia.org/wiki/Enzyme_inhibitor"},{"name":"Phosphatidylinositol","weight":0.11418,"wikipedia_article":"http://en.wikipedia.org/wiki/Phosphatidylinositol"},{"name":"Therapy","weight":0.101782,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Lymphoma","weight":0.0393397,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphoma"},{"name":"Functional selectivity","weight":0.0300804,"wikipedia_article":"http://en.wikipedia.org/wiki/Functional_selectivity"},{"name":"Kinase","weight":0.0142619,"wikipedia_article":"http://en.wikipedia.org/wiki/Kinase"}]}
